Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801226 · ClinicalTrials.gov registry record · Early Phase 1
Zero Sodium Peritoneal Dialysate Protocol Pilot Study
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT03801226 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 12 participants.
The verdict
NCT03801226, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The following pilot study will be undertaken to determine the effects of use of a zero-sodium peritoneal dialysate solution (10% dextrose in sterile water) on sodium removal as compared to a standard peritoneal dialysis solution.
Interventions
- DRUG Two-hour dwell with 10% dextrose in sterile water
- DRUG Two-hour dwell with Dianeal Low-Calcium with 4.25% Dextrose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2019-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801226
The ClinicalTrials.gov registry entry for NCT03801226 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Two-hour dwell with 10% dextrose in sterile water is the first listed.
NCT03801226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801226 about?
NCT03801226 is a clinical study titled "Zero Sodium Peritoneal Dialysate Protocol Pilot Study". The following pilot study will be undertaken to determine the effects of use of a zero-sodium peritoneal dialysate solution (10% dextrose in sterile water) on sodium removal as compared to a standard peritoneal dialysis solution.
What is the current status of trial NCT03801226?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2018-12-01. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03801226?
The interventions under investigation include: Two-hour dwell with 10% dextrose in sterile water (DRUG), Two-hour dwell with Dianeal Low-Calcium with 4.25% Dextrose (DRUG).
Who is sponsoring clinical trial NCT03801226?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.